Immunoassay in RD Market is expected to reach USD 475.3 million Augmenting at a CAGR 8.18% by the year 2023
Global Immunoassay in Ramp;D Market is expected to register a CAGR of 8.18% and is anticipated to reach USD 475.3 Million by 2023.
The Global Immunoassay in Ramp;D Market studies the overall dynamics and trends of the market in terms of various segments and regional outlook for the period of 2017 to 2023. The report offers of historic and future market scenario in terms of market value, share and critical developments taking place in the industry. Market size, forecast, trends of each country and region are studied in the report for the focus period of 2017 to 2023.
We can provide sample pages for a better understanding of this report.
Request Sample of This Report @ http://www.amecoresearch.com/sample/12947
Qualitative assessment tools such as PEST analysis, cost structure analysis and regulatory compliance for pharmaceutical products are offered in the report. The report also comprises Pipeline Analysis which helps understand the comprehensive forecast scenario of the market in terms of value and dynamics. The report analyses the recent drug approval trends and market dynamics such as drivers, restrains, and opportunities, industry trends and future outlook in the Global Immunoassay in Ramp;D Market.
The report represents key players operating in the market along with its competitive landscape. The competitive landscape includes player positioning analysis, competitive matrix and market share analysis of the key players operating in the industry. The market attractive index highlights the most lucrative regional market to invest in the market.
The market is studied for regions such as North America (U.S., and Canada), Europe (U.K., Germany, France, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East amp; Africa (GCC, South Africa, and Rest of Middle East amp; Africa).
What is the market size in 2018 and the growth rate of the Global Immunoassay in Ramp;D Market?
What is the market drivers, restrains, opportunities governing the Global Immunoassay in Ramp;D Market?
Which are the largest and the fastest growing segments in the Global Immunoassay in Ramp;D Market?
Who are the key players operating in the market and their market position?
What is the pipeline scenario, drug pricing analysis and technological development in the market?
View Detail Report With Complete Table Of Content@ http://www.amecoresearch.com/market-report/immunoassay-in-r-d-market-12947
Global Immunoassay in Ramp;D Market: Information by Product amp; Service (Kits and Reagents and Others), Type (Radioimmunoassay and others), Application (Infectious Diseases, Cancer Research, Endocrinology and Others), End User and Regionshy; - Forecast till 2023
The Global Immunoassay in Ramp;D Market is expected to register a CAGR of 8.18% and is anticipated to reach USD 475.3 Million by 2023. Immunoassays are in-vitro tests that use antigen-antibody reaction to detect the concentrations of a wide range of biological substances in the blood and other fluids. Immunoassays are extensively used in several areas of pharmaceutical research such as therapeutic drug monitoring, disease diagnosis, clinical pharmacokinetic, and bioequivalence studies in drug discovery, among others.
The growing incidence rate of chronic and infectious diseases, increased research and development investment (Ramp;D), and technological advancements are the major drivers propelling market growth. However, the high cost of immunoassay procedures and the high price of immunoassay systems constrain the growth of the market.
The increase in the incidence rates of diseases such as kidney problems, thyroid problems, adrenal gland tumors, and heart ailments is expected to drive the growth of the market. For instance, according to the data published by the Centers for Disease Control and Prevention in 2017, the American Heart Association stated in 2015 that every year about 7,35,000 Americans have a heart attack. Moreover, the increased investments by various government and non-governmental organizations in research has fueled the growth of the market. Additionally, technological advancements in immunoassay testing are likely to support market growth. On the other hand, the high cost of immunoassay procedures and the high price of immunoassay systems is anticipated to hamper the market growth.
The global immunoassay in Ramp;D market has been segmented into type, application, and end user. By type, the market has been segmented into Enzyme-Linked Immunosorbent Assay (ELISA), Enzyme-Linked Immunospot Assay (ELISpot), Radioimmunoassay (RIA), Chemiluminescence (CLIA), Fluoroimmunoassay, and Others. On the basis of application, the market has been segmented into infectious diseases, cancer research, endocrinology, autoimmune diseases, and others. By end-user, the market has been segmented pharmaceutical and biotechnology companies, academic institutions and laboratories, and others. The pharmaceutical and biotechnology companies segment accounted for a market value of USD 174.3 million in 2017.
The prominent players in the global immunoassay in Ramp;D market are Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), Siemens Healthineers (Germany), Becton, Dickinson and Company (US), Danaher Corporation (US), bioMeacute;rieux Inc. (France), Abbott Laboratories (US), F. Hoffmann-La Roche Ltd (Switzerland), Sysmex Corporation (Japan) and Abcam plc (United Kingdom).
Some of the key strategies followed by the players operating in the global immunoassay in Ramp;D market were innovation, product development, acquisition, and expansion.
The global immunoassay in Ramp;D market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is estimated to dominate the global immunoassay in Ramp;D market during the forecast period. This is attributed to the increasing number of research projects in laboratories, as research laboratories play a vital role in the growth of the regional market. Besides, several research grants are given by governmental agencies. The European market for immunoassay in Ramp;D is expected to be the second-largest during the forecast period. The growing adoption in diagnostic measures is expected to boost the growth of the market in this region.
Additionally, the companies operating in the market are particularly focusing on mergers and acquisition which is expected to support the market growth. Asia-Pacific is estimated to be the fastest growing market due to the developing healthcare infrastructure and increasing disposable income. In addition to this, improving healthcare infrastructure has increased the number of research activities in the region. Moreover, in the Asia-Pacific region, South Korea accounted for a market share of 10.1% in 2017. Furthermore, the market in the Middle East amp; Africa is expected to witness steady growth due to limited access to healthcare facilities.
In November 2018, bioMeacute;rieux announced the acquisition of a majority shareholding in Suzhou Hybiome Biomedical Engineering Co. Ltd (China). With this acquisition, the company strengthened its presence in China and consequently, in the global immunoassay in Ramp;D market.
In March 2018, Hoffmann-La Roche Ltd launched its first fully automated Zika IgG immunoassay to help detect the Zika virus. The official name of this diagnostic test is Elecsys Zika IgG immunoassay. It is available in all countries, which require a CE mark.
In October 2017, Abbott announced the US Food amp; Drug Administration (FDA) clearance for its Alinity CI-Series instruments for clinical chemistry and immunoassay diagnostics.
Global Immunoassay in Ramp;D Market, by Type
Enzyme-Linked Immunosorbent Assay (ELISA)
Enzyme-Linked Immunospot Assay (ELISpot)
Global Immunoassay in Ramp;D Market, by Application
Global Immunoassay in Ramp;D Market, by End User
Pharmaceutical and Biotechnology Companies
Academic Institutions and Laboratories
Global Immunoassay in Ramp;D Market, by Region
Rest of Western Europe
Rest of Asia-Pacific
Middle East amp; Africa
Available Additional Customizations
Boditech Med, Inc.
Ortho Clinical Diagnostics
Supply amp; Demand Analysis
Medical device manufacturers and distributors
Government research organizations
Hospitals and clinics
Table Of Contents
Immunoassay in Ramp;D Market Research Report - Global Forecast till 2023
1 Report Prologue
2 Market Introduction
3 Research Methodology
4 Market Dynamics
5 Market Factor Analysis
6 Global Immunoassays in Ramp;D Market, by Product amp; Service
7 Global Immunoassays in Ramp;D Market, by Type
8 Global Immunoassays in Ramp;D Market, by Application
9 Global Immunoassays in Ramp;D Market, by End User
10 Global Immunoassays in Ramp;D Market, by Region
11 Company Landscape
12 Company Profiles
Quick Buy This Premium Report From Here: http://www.amecoresearch.com/buy/12947
Ameco Research is the one spot destination for all your research needs. Ameco Research holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.
Email: firstname.lastname@example.org | +1 407 915 4157